Previous 10 | Next 10 |
home / stock / flhlf / flhlf news
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA Canada NewsWire Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament's botanical psilocybin drug candidate VANCOUVER, BC , Jan. 17, 2024 /CNW/ - Filament Healt...
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , Jan. 2, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development comp...
2023-12-20 03:50:21 ET More on Filament Health Filament Health raises $14.4M via issuance of senior secured convertible notes Filament Health signs term sheet for a $14.4M convertible note Historical earnings data for Filament Health Financial information for...
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire VANCOUVER, BC , Dec. 19, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Compan...
FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE Canada NewsWire VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or t...
FILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING Canada NewsWire VANCOUVER, BC , Dec. 11, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedel...
FILAMENT HEALTH FILES AMENDED PRO FORMA FINANCIAL STATEMENTS Canada NewsWire VANCOUVER, BC , Dec. 7, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural ps...
2023-12-06 11:26:25 ET More on Filament Health Filament Health signs term sheet for a $14.4M convertible note Historical earnings data for Filament Health Financial information for Filament Health For further details see: Filament Health raises $14.4M via...
FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATION Canada NewsWire ...
--News Direct-- Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce the signing of a non-binding term sheet for potential funding of up to US$14.4 million. The funding is in collaboration with an affiliate of Helena Partners Inc., a Cayman-Islands-based advis...
News, Short Squeeze, Breakout and More Instantly...
Filament Health Company Name:
FLHLF Stock Symbol:
OTCMKTS Market:
The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for schizophrenia and other mental conditions that present psychotic symptoms Jaguar to receive percent of milestone payments and increasing royalties upon commercializat...
FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Canada NewsWire VANCOUVER, BC , May 14, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage na...
2024-04-05 10:30:00 ET April 5, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies offer therapies for cancer, eye di...